Drugs children take for attention deficit hyperactivity disorder should carry stronger warnings about the risk of side effects like hallucinations and paranoia, the FDA states.
The agency since 2000 has received more than 500 reports of psychosis in children 10 and younger who took attention drugs such as Adderall, Strattera, and Ritalin.
``Signs and symptoms of psychosis or mania, particularly hallucinations, can occur in some patients with no identifiable risk factors,'' an agency review dated March 3 said. The documents were posted on the FDA Web site in advance of a panel meeting next week.
For more information, go to Bloomberg or to the FDA site here (PDF).